ALLK

Allakos (ALLK)

Allakos Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ALLK

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/10	06:09	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ALLK	Allakos Inc
2024/05/10	05:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALLK	Allakos Inc
2024/05/10	05:02	GlobeNewswire Inc.	Allakos Provides Business Update and Reports First Quarter 2024 Financial Results	NASDAQ:ALLK	Allakos Inc
2024/03/15	05:02	GlobeNewswire Inc.	Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:ALLK	Allakos Inc
2024/03/07	08:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALLK	Allakos Inc
2024/03/07	08:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALLK	Allakos Inc
2024/03/06	06:22	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ALLK	Allakos Inc
2024/03/05	07:52	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ALLK	Allakos Inc
2024/02/26	21:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALLK	Allakos Inc
2024/02/26	21:02	GlobeNewswire Inc.	Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024	NASDAQ:ALLK	Allakos Inc
2024/02/22	07:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALLK	Allakos Inc
2024/02/22	07:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALLK	Allakos Inc
2024/02/22	07:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALLK	Allakos Inc
2024/02/17	09:08	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ALLK	Allakos Inc
2024/02/15	06:01	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ALLK	Allakos Inc
2024/02/14	22:34	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ALLK	Allakos Inc
2024/02/12	21:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALLK	Allakos Inc
2024/02/12	21:02	GlobeNewswire Inc.	Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition	NASDAQ:ALLK	Allakos Inc
2024/02/03	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALLK	Allakos Inc
2024/02/03	02:31	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:ALLK	Allakos Inc
2024/01/27	06:20	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:ALLK	Allakos Inc
2024/01/26	23:21	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ALLK	Allakos Inc
2024/01/17	07:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALLK	Allakos Inc
2024/01/16	21:02	GlobeNewswire Inc.	Allakos Announces a Restructuring to Focus on Development of AK006	NASDAQ:ALLK	Allakos Inc
2024/01/16	21:00	GlobeNewswire Inc.	Allakos Announces Phase 2 Lirentelimab Trials in Atopic Dermatitis and Chronic Spontaneous Urticaria Did Not Meet Their Primary Endpoints	NASDAQ:ALLK	Allakos Inc
2024/01/06	06:02	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:ALLK	Allakos Inc
2023/12/06	08:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALLK	Allakos Inc
2023/12/06	08:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALLK	Allakos Inc
2023/12/06	08:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALLK	Allakos Inc
2023/12/05	05:49	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ALLK	Allakos Inc